Literature DB >> 7441659

Idiopathic chondrolysis--an immunopathologic study.

J H Herman, E B Herzig, J D Crissman, M V Dennis, E V Hess.   

Abstract

Investigations were performed to determine the potential of an immunologically-mediated basis underlying development of severe bilateral knee chondrolysis arising over a 2-yr period in a 29-yr-old man. Humoral and cell-mediated immune responses to autologous and homologous articular cartilage proteoglycan and collagen rich fractions were identified in sequential studies. Employing gradient derived peripheral blood mononuclear cells there was demonstration of spontaneous, T cell mitogen augmented and autologous cartilage antigen-induced release of factors capable of degrading articular cartilage proteoglycans and inhibiting chondrocyte glycosaminoglycan synthesis. Evidence has thus been provided incriminating immunologic events, likely functioning in a perpetuant manner, in the pathogenesis of this chondrolytic process.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7441659

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  4 in total

Review 1.  Cytokine modulation of chondrocyte metabolism--in vivo and in vitro effects of piroxicam.

Authors:  J H Herman; A M Appel; R C Khosla; K S Kelch; E V Hess
Journal:  Inflammation       Date:  1984-06       Impact factor: 4.092

2.  Mobility with rigidity: a view of the spine.

Authors:  E G Bywaters
Journal:  Ann Rheum Dis       Date:  1982-04       Impact factor: 19.103

3.  Production of IL-6 by T cells from the femoral head of patients with rapidly destructive coxopathy (RDC).

Authors:  M Tamai; K Sagawa; R Kawabata; A Inoue; K Itoh
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

4.  Idiopathic chondrolysis of hip in children: New proposal and implication for radiological staging.

Authors:  C Amarnath; Priya Muthaiyan; T Helen Mary; Shilpa Mohanan; K Gopinathan
Journal:  Indian J Radiol Imaging       Date:  2018 Apr-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.